Previous close | 21.22 |
Open | 21.27 |
Bid | 21.71 x 300 |
Ask | 21.76 x 200 |
Day's range | 21.01 - 22.83 |
52-week range | 16.95 - 49.50 |
Volume | |
Avg. volume | 1,523,052 |
Market cap | 1.789B |
Beta (5Y monthly) | 1.77 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Beam Therapeutics (BEAM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Gene editing is one of the most exciting and interesting investment opportunities. So, here are two stocks to consider buying in the space. The post 2 stocks to buy in the high potential gene editing space appeared first on The Motley Fool UK.